Moneycontrol PRO
HomeAuthorR sree ram Opinion

R. Sree Ram

News Editor

Moneycontrol

After balance sheet repair, the difficult part awaits Suzlon

BUSINESS

After balance sheet repair, the difficult part awaits Suzlon

The company has to rapidly grow its business volumes

Moneycontrol Pro Panorama | Investors rediscover Coal India

BUSINESS

Moneycontrol Pro Panorama | Investors rediscover Coal India

In today's edition of Moneycontrol Pro Panorama: Nifty fiscal earnings may outpace last year, slowing inflation a good omen for investors, work beyond the 9-to-5 norm, artificial intelligence invades creativity, and more

Nifty FY24 earnings set to outpace FY23 despite mixed results

BUSINESS

Nifty FY24 earnings set to outpace FY23 despite mixed results

Oil & gas, automobiles and financial services sectors are projected to drive Nifty 50 index’s earnings in FY24

How OLX is reshaping CarTrade Tech’s growth outlook

BUSINESS

How OLX is reshaping CarTrade Tech’s growth outlook

After the closure of OLX car trading platform, CarTrade Tech is left with the classifieds business, the largest such platform in India

Moneycontrol Pro Panorama | The indomitable faith of domestic investors  

BUSINESS

Moneycontrol Pro Panorama | The indomitable faith of domestic investors  

In today's edition of Moneycontrol Pro Panorama: New course for Indian management education, how behavioural traits influence your investment, why no rally yet by Rahul Gandhi in poll-bound Rajasthan, generative AI and white-collar worker, and more

Radico Khaitan is extracting a good price for its premium drive

BUSINESS

Radico Khaitan is extracting a good price for its premium drive

The stock is valued at 60 times estimated FY24 earnings, not significantly lower than United Spirits

Moneycontrol Pro Panorama | E-commerce firms crack growth code, earnings should follow suit 

BUSINESS

Moneycontrol Pro Panorama | E-commerce firms crack growth code, earnings should follow suit 

In today's edition of Moneycontrol Pro Panorama: Investors pour in for REITs and InvITs, rooftop power solar energy sale needs a boost, gap between job growth and working age population lowers, Mizoram poll campaign an example for all, and more

Chart of the Day: How Zomato’s membership gambit revived growth

BUSINESS

Chart of the Day: How Zomato’s membership gambit revived growth

Average monthly transacting customers on the food delivery platform rose sequentially for the second consecutive quarter

NTPC’s higher capex plans should reassure BHEL investors

BUSINESS

NTPC’s higher capex plans should reassure BHEL investors

The thermal capacity awards target has been raised to 11,200 MW from 7,200 MW

Revenue guidance has been lowered, but growth in GCCs is a long-term opportunity: Amit Chadha, LTTS CEO

TRENDS

Revenue guidance has been lowered, but growth in GCCs is a long-term opportunity: Amit Chadha, LTTS CEO

India’s share in the global ER&D sourcing market is expected to increase more than three-fold by 2030, says LTTS CEO

Moneycontrol Pro Panorama | Consolidation wave spreads in healthcare sector

BUSINESS

Moneycontrol Pro Panorama | Consolidation wave spreads in healthcare sector

In this edition of Moneycontrol Pro Panorama: How Cipla built a billion-dollar business in US, India’s economic ascent explained, groundwater crisis needs urgent response, consumer sentiments declined for the second week, and more

Chart of the Day: How Cipla built a billion-dollar US business in a decade

BUSINESS

Chart of the Day: How Cipla built a billion-dollar US business in a decade

The company’s US revenues are projected to move closer to $900 million in FY24 and $1 billion in FY25, up from $148 million in FY15

Tech Mahindra’s dismal Q2 calls for reset of investor expectations

TRENDS

Tech Mahindra’s dismal Q2 calls for reset of investor expectations

Industry headwinds and company specific issues can lead to weak performance in the near term

Sharda Cropchem’s weak result has a cautionary message for UPL investors

BUSINESS

Sharda Cropchem’s weak result has a cautionary message for UPL investors

Agrochemicals' revenues plunged in Q2 on steep price erosion in international markets

Infosys trumps TCS and HCL in order wins but lags in revenue collection

BUSINESS

Infosys trumps TCS and HCL in order wins but lags in revenue collection

TCS and HCL have lower receivables than Infosys

Pharma Q2 growth in India slows, hopes hinge on US  

TRENDS

Pharma Q2 growth in India slows, hopes hinge on US  

Growth in the Indian pharma market slowed to 7 percent in Q2 of FY24 from 8.5 percent in Q1

Moneycontrol Pro Panorama | An addiction that's hard to kick  

BUSINESS

Moneycontrol Pro Panorama | An addiction that's hard to kick  

In this edition of Moneycontrol Pro Panorama: China sitting on a ticking time bomb, TCS's shareholder payout sees a meteoric rise, investors need to keep an eye on Iran, Hamas attack adds to Middle East conflict, and more

Chart of the Day: How TCS returns large amount of cash every year to shareholders

TRENDS

Chart of the Day: How TCS returns large amount of cash every year to shareholders

Total payouts by TCS increased by 9.6 percent per annum in the past four years to Rs 42,079 crore in FY23

Moneycontrol Pro Panorama | Cricket adds to the festive cheer 

BUSINESS

Moneycontrol Pro Panorama | Cricket adds to the festive cheer 

In today's edition of Moneycontrol Pro Panorama: India’s economy already flush with festive cheer, the politics of caste census, MPC's October dilemma, are celebrity investments a boon for startups, and more

Chart of the Day: Hospitals trump other sectors in credit upgrades

TRENDS

Chart of the Day: Hospitals trump other sectors in credit upgrades

Healthcare sector saw higher upgrades in the last 18 months helped by the rise in hospital bed occupancy and realisations

Fortis and Apollo: Scale economics underpins Kolkata acquisitions

BUSINESS

Fortis and Apollo: Scale economics underpins Kolkata acquisitions

Expansion plans of hospital chains are centred on building large format facilities and business clusters

How large cap IT can diverge from Accenture on order wins

TRENDS

How large cap IT can diverge from Accenture on order wins

Infosys, TCS, HCL have won several large projects in Q2 with total revenue potential of more than $1 billion

How Mankind Pharma is consistently outperforming the Indian drug industry

BUSINESS

How Mankind Pharma is consistently outperforming the Indian drug industry

Focus on chronic therapy drugs, consumer healthcare business and large brands are helping the company

Moneycontrol Pro Panorama | Trouble in the skies  

TRENDS

Moneycontrol Pro Panorama | Trouble in the skies  

In today's edition of Moneycontrol Pro Panorama: US-China tech war opens new doors for India, fintech regulations need to be clearer, coal demand in India thrives post-COVID, India could learn from China’s EV plans, and more

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347